CAJ | 학술논문

目的分析我院心脏中心8年来收治5720例急性心肌梗死(AMI)患者的临床特点和院内死亡原因.方法 2002年1月1日至2009年12月31日期间我院心脏中心收治AMI患者5720例.根据年龄分为≤45岁组、46～75岁组和＞75岁组,统计分析其发病率、死因、是否接受PCI介入治疗及接受介入治疗后的死亡情况以及性别对死因的影响.结果 2002-2009年不同年龄组AMI发病率男性均高于女性,＞75岁组女性发病率显著升高,但仍低于男性.所有AMI患者接受介入治疗的比例明显升高,接受介入治疗患者每年病死率明显下降.死亡原因前三位是急性心力衰竭、心源性休克及急性心力衰竭合并心源性休克,且在女性和＞75岁患者急性心力衰竭导致的死亡明显增加.结论我院AMI住院人数逐年增加,接受介入治疗能降低病死率,＞75岁老年人血运重建治疗仍然是可行及安全的.
목적 분석아원심장중심8년래수치5720례급성심기경사(AMI)환자적림상특점화원내사망원인.방법 2002년1월1일지2009년12월31일기간아원심장중심수치AMI환자5720례.근거년령분위≤45세조、46～75세조화＞75세조,통계분석기발병솔、사인、시부접수PCI개입치료급접수개입치료후적사망정황이급성별대사인적영향.결과 2002-2009년불동년령조AMI발병솔남성균고우녀성,＞75세조녀성발병솔현저승고,단잉저우남성.소유AMI환자접수개입치료적비례명현승고,접수개입치료환자매년병사솔명현하강.사망원인전삼위시급성심력쇠갈、심원성휴극급급성심력쇠갈합병심원성휴극,차재녀성화＞75세환자급성심력쇠갈도치적사망명현증가.결론 아원AMI주원인수축년증가,접수개입치료능강저병사솔,＞75세노년인혈운중건치료잉연시가행급안전적.
Objective The study aimed to analyze the clinical features and the causes of hospital death among the 5720 acute myocardial infarction(AMI)patients from Cardiology Center,Beijing Chao-Yang Hospital during the last 8 years. Methods A total of 5720 AMI patients received treatment in the Cardiology Center from January 1st ,2002 to December 31th ,2009 were retrospectively reviewed. All patients were classified according to age into 3 groups of ≤45,46 -75,and ＞ 75 years old. The morbidity,cause of death ,whether they had the PCI therapy,mortality after PCI and the impact of gender on the cause of death were observed respectively. Results The morbidity rate of male was significantly higher than female in all three groups,and the study also found that the morbidity rate of female was significantly higher in the group of ＞ 75 years old,which however was still lower than that of male. The AMI patients were more likely to accept PCI therapy,which could significantly reduce the mortality rate. The top 3 causes of death included acute heart failure(AHF),cardiogenic shock(CGS)and AHF combined with CGS. In addition,AHF caused significantly more death in female and older(＞ 75 years old)patients. Conclusions The morbidity rate of AMI patients in Beijing Chao-Yang Hospital increased year by year. And PCI therapy could reduce the mortality rate of all groups. Revascularization treatment seems to be feasible and safe for the patients older than 75 years old.